Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Detalles Bibliográficos
Autores principales: Ke, Qiao, Xin, Fuli, Fang, Huipeng, Zeng, Yongyi, Wang, Lei, Liu, Jingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210665/
https://www.ncbi.nlm.nih.gov/pubmed/35747141
http://dx.doi.org/10.3389/fimmu.2022.952446
_version_ 1784730203520499712
author Ke, Qiao
Xin, Fuli
Fang, Huipeng
Zeng, Yongyi
Wang, Lei
Liu, Jingfeng
author_facet Ke, Qiao
Xin, Fuli
Fang, Huipeng
Zeng, Yongyi
Wang, Lei
Liu, Jingfeng
author_sort Ke, Qiao
collection PubMed
description
format Online
Article
Text
id pubmed-9210665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92106652022-06-22 Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review Ke, Qiao Xin, Fuli Fang, Huipeng Zeng, Yongyi Wang, Lei Liu, Jingfeng Front Immunol Immunology Frontiers Media S.A. 2022-06-07 /pmc/articles/PMC9210665/ /pubmed/35747141 http://dx.doi.org/10.3389/fimmu.2022.952446 Text en Copyright © 2022 Ke, Xin, Fang, Zeng, Wang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ke, Qiao
Xin, Fuli
Fang, Huipeng
Zeng, Yongyi
Wang, Lei
Liu, Jingfeng
Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title_full Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title_fullStr Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title_full_unstemmed Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title_short Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
title_sort corrigendum: the significance of transarterial chemo(embolization) combined with tyrosine kinase inhibitors and immune check point inhibitors for unresectable hepatocellular carcinoma in the era of systemic therapy: a systematic review
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210665/
https://www.ncbi.nlm.nih.gov/pubmed/35747141
http://dx.doi.org/10.3389/fimmu.2022.952446
work_keys_str_mv AT keqiao corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview
AT xinfuli corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview
AT fanghuipeng corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview
AT zengyongyi corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview
AT wanglei corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview
AT liujingfeng corrigendumthesignificanceoftransarterialchemoembolizationcombinedwithtyrosinekinaseinhibitorsandimmunecheckpointinhibitorsforunresectablehepatocellularcarcinomaintheeraofsystemictherapyasystematicreview

Ejemplares similares